Bifunctional Compounds for Extracellular Target Degradation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional protein-directed therapeutics are limited in effectively targeting and degrading extracellular proteins that are undruggable due to incomplete understanding of their molecular functions, making it difficult to inhibit their activity using traditional methods.
Innovation Solution
Development of bifunctional compounds that bind to extracellular targets and a membrane-bound receptor associated with a degradation pathway, facilitating the degradation of these proteins through pathways like receptor-mediated endocytosis or lysosomal degradation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If conventional chemical inhibition methods are used to target extracellular proteins, then the therapeutic approach is limited to druggable targets with well-understood molecular functions, but many extracellular targets remain undruggable due to incomplete understanding of their molecular functions or large active sites
Solution Approach 1:
The bifunctional compound is divided into two distinct functional moieties: a first moiety that binds to the extracellular target protein and a second moiety that binds to a membrane-bound receptor associated with degradation pathways. This segmentation allows each moiety to independently perform its binding function, enabling the system to target previously undruggable extracellular proteins while utilizing existing cellular degradation machinery.
Solution Approach 2:
The invention introduces a membrane-bound receptor as an intermediary component that mediates the degradation process. The receptor acts as a bridge between the extracellular target protein and the cellular degradation pathway, facilitating the internalization and degradation of the target without requiring direct inhibition of the target's active site.
2Reliability
If traditional chemical inhibition is used to block protein function, then the approach may fail for proteins with multiple functional sites or large interaction areas, but the bifunctional compound approach eliminates the entire target molecule through degradation
Solution Approach 1:
Instead of attempting to inhibit the function of an extracellular target protein through direct binding to its active site, the invention inverts the approach by recruiting the protein's natural degradation machinery to eliminate the entire protein molecule. This is achieved by linking the target protein to a membrane-bound receptor that triggers internalization and degradation, thereby eliminating the need to directly inhibit complex active sites.
Solution Approach 2:
The invention leverages the cell's own degradation pathways and machinery to eliminate the extracellular target protein. By recruiting endogenous degradation systems through the membrane-bound receptor, the approach allows the biological system to perform the elimination function itself, rather than requiring external inhibition mechanisms.
3Duration of action of stationary object
If the bifunctional compound approach is used to degrade extracellular targets through receptor-mediated endocytosis, then the entire target molecule is eliminated providing lasting therapeutic effect, but the compound requires binding to both the extracellular target and a membrane-bound receptor
Solution Approach 1:
The invention merges two separate binding functions into a single bifunctional compound molecule. The first moiety binds to the extracellular target protein while the second moiety binds to the membrane-bound receptor, creating a unified structure that can simultaneously engage both targets and facilitate degradation through receptor-mediated endocytosis.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The bifunctional compounds effectively reduce the levels of extracellular targets by directing them for irreversible degradation, offering a potent alternative to traditional therapies by eliminating the entire target molecule, even for proteins with multiple functional sites or large interaction areas, thus providing a rapid and lasting therapeutic effect.
Implementation Method 1
mediating a reduction of the level of said extracellular target by tagging it for degradation in a degradation pathway (e.g., receptor mediated endocytosis or lysosomal degradation)
Data Source
AI summary
The present disclosure features bifunctional compounds for the degradation of extracellular targets, as well as compositions and related methods thereof.